B

Biodyne Co Ltd
KOSDAQ:314930

Watchlist Manager
Biodyne Co Ltd
KOSDAQ:314930
Watchlist
Price: 19 660 KRW -4.79% Market Closed
Market Cap: 579.5B KRW
Have any thoughts about
Biodyne Co Ltd?
Write Note

Biodyne Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biodyne Co Ltd
Cash & Cash Equivalents Peer Comparison

Comparables:
145720
J
287410
C
214150
L
085370
O
048260

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Biodyne Co Ltd
KOSDAQ:314930
Cash & Cash Equivalents
â‚©9.7B
CAGR 3-Years
48%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Dentium Co Ltd
KRX:145720
Cash & Cash Equivalents
â‚©86.6B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Cash & Cash Equivalents
â‚©52.9B
CAGR 3-Years
32%
CAGR 5-Years
115%
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Cash & Cash Equivalents
â‚©24.3B
CAGR 3-Years
-27%
CAGR 5-Years
2%
CAGR 10-Years
N/A
L
Lutronic Corp
KOSDAQ:085370
Cash & Cash Equivalents
â‚©50B
CAGR 3-Years
64%
CAGR 5-Years
69%
CAGR 10-Years
33%
O
OsstemImplant Co Ltd
KOSDAQ:048260
Cash & Cash Equivalents
â‚©316.6B
CAGR 3-Years
40%
CAGR 5-Years
22%
CAGR 10-Years
25%

See Also

What is Biodyne Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
9.7B KRW

Based on the financial report for Dec 31, 2023, Biodyne Co Ltd's Cash & Cash Equivalents amounts to 9.7B KRW.

What is Biodyne Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
47%

Over the last year, the Cash & Cash Equivalents growth was -9%. The average annual Cash & Cash Equivalents growth rates for Biodyne Co Ltd have been 48% over the past three years , 47% over the past five years .

Back to Top